SEC Form 4 · accession 0001179110-18-010499
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Aug 8, 2018
Accepted (ET)
Aug 10, 2018 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 8, 2018 | M | 1,346 | $0.00 | A | 172,869 | D | |
| Common Stock | Aug 8, 2018 | S | 400 | $29.00 | D | 172,469 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | Aug 8, 2018 | M | 1,346 | D | — | — | Common Stock | 1,346 | 13,453 | D |
Explanation of responses
- F1Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- F2Includes 476 shares acquired under the issuer's employee stock purchase plan at a purchase price of $14.20 per share on July 31, 2018.
- F3This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F4Restricted Stock Units convert into common stock on a one-for-one basis.
- F5Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.